Abstract
BACKGROUND: Acute myeloid leukemia (AML) patients with non-remission (NR) after the first cycle of standard induction chemotherapy remain a challenge ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
